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Abstract
In this study, we formulate a computational reaction model following a chemical kinetic theory
approach to predict the binding rate constant for the siRNA-RISC complex formation reaction.
The model allowed us to study the potency difference between 2-nt 3' overhangs against blunt-
ended siRNA molecules in an RNA interference (RNAi) system. The rate constant predicted by
this model was fed into a stochastic simulation of the RNAi system (using the Gillespie stochastic
simulator) to study the overall potency effect. We observed that the stochasticity in the
transcription/translation machinery has no observable effects in the RNAi pathway. Sustained gene
silencing using siRNAs can be achieved only if there is a way to replenish the dsRNA molecules in
the cell. Initial findings show about 1.5 times more blunt-ended molecules will be required to keep
the mRNA at the same reduced level compared to the 2-nt overhang siRNAs. However, the mRNA
levels jump back to saturation after a longer time when blunt-ended siRNAs are used. We found
that the siRNA-RISC complex formation reaction rate was 2 times slower when blunt-ended
molecules were used pointing to the fact that the presence of the 2-nt overhangs has a greater
effect on the reaction in which the bound RISC complex cleaves the mRNA.
Introduction
RNA interference (RNAi) refers to a post-transcriptional
gene silencing mechanism with potential therapeutic
application for the treatment of various diseases including
cancer, viral infections, and neurodegenerative disorders
[1]. The RNAi pathway involves the introduction of a
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small interfering double stranded (ds) RNA, siRNA, pro-
moting degradation of a target mRNA [2]. RNAi mole-
cules have sequence complementation to that of the
siRNA antisense (or guide) strand ultimately inhibiting
the translation of the encoded protein. Currently, RNAi is
being extensively used to study the functions of individual
genes based on its intrinsic property of regulating the
expression of a distinct mRNA species in mammalian cells
[3,4] as well as offering additional improvements over
alternative technologies including knock-out by homolo-
gous recombination and antisense. In Ref. [5], the authors
performed a comparative analysis of the suppressive
effects of three knockdown methods, namely, methods
based on RNA interference (RNAi), antisense ODNs, and
ribozymes, using a luciferase reporter system. Their dose-
response experiments revealed that the IC50 value for the
siRNA was about 100-fold lower than that of the antisense
ODN besides providing useful information about the
positional effects in RNAi.
An important consideration towards selecting an effective
siRNA-based gene silencing tool is the duration of effect
and efficacy of a candidate molecule. Extensive studies
determining the intensity of gene silencing mediated by
siRNA were reported in Ref. [6] &[7] by finding the opti-
mal sequence of siRNA. Upon introduction of siRNAs
with an optimized sequence into cells, the target mRNA is
degraded resulting in a lowering of the corresponding
protein. It has been reported that 21-nt siRNAs with 2-nt
3' overhangs are more potent than other types of siRNA
molecules in terms of reduction in protein levels [8].
Recent studies have reported a higher potency effect due
to 27-mer RNA duplexes which we will consider in the
Discussions section.
Upon introduction into a cell, a siRNA molecule will be
diluted over time due to its degradation and cellular pro-
liferation resulting in a decrease in its effective concentra-
tion. Consequently, the expression level of the target gene
will return to a normal level after the gene silencing
period, dependent upon the number of siRNA molecules
actually entering the cell. To use siRNA for silencing target
gene expression, it is important to understand how long
the target mRNA or protein is suppressed by the siRNA.
Maximal inhibitory efficiency of siRNA, a parameter that
has frequently been used to express the potency of each
siRNA, should be discussed in context with the duration
or persistence of its effect.
Figure 1 illustrates the RNAi system which consists of the
following major steps [9]. Long dsRNAs (e.g. >200 base
pairs) get processed into 19–25 nucleotide (nt) small
interfering RNAs (siRNAs) by an RNase III-like enzyme
called Dicer (initiation step) or in the case of mammalian
RNAi are introduced to cells directly as "active"(19–25 nt)
siRNA molecules. The siRNAs assemble into endoribonu-
clease containing complexes known as RNA-induced
silencing complexes (RISCs), unwinding in the process.
Activated RISC then binds to complementary transcript by
base pairing interactions between the siRNA antisense
strand and the mRNA. The bound mRNA is cleaved and
sequence specific degradation of mRNA results in gene
silencing. We refer to the aberrant pieces of RNA after
cleavage as "garbage RNA" (referred to as gRNA in this
paper). It has been reported that a substantial fraction of
the siRNAs in Caenorhabditis elegans is not derived directly
from the introduced dsRNA [10]. To explain this, two
amplification routes have been proposed: primed and
unprimed amplification [11-13]. In both cases, RNA-
dependent RNA polymerase (RDR) synthesizes dsRNA: in
the case of primed amplification siRNA binds to mRNA to
initiate dsRNA synthesis, whereas in the case of unprimed
amplification the mere presence of aberrant garbage RNA
is sufficient to trigger RDR. In short, the generally accepted
pathway of RNA silencing consists of the degradation of
mRNA via RISC and an amplification pathway through
RDR.
In this study, we use computational modeling to investi-
gate the potency effects of the widely used 21-nt siRNAs
with 2-nt 3' overhangs as compared to blunt-ended siRNA
molecules to assess the effectiveness of the latter as an
alternative structural entity. We have developed a simple
systems biology simulation to quantitatively assess both
the intensity and duration of gene silencing by siRNA. The
stochastic simulation framework presented here allows us
to predict some quantitative and qualitative aspects of the
RNAi system for the two different types of siRNAs.
RNAi system overviewFigure 1
RNAi system overview.
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Materials and methods
The reaction model was built to investigate the potency
difference between 2-nt 3' overhangs and blunt-ended
siRNA molecules. We identified that the siRNA-RISC com-
plex formation reaction rate was altered due to the differ-
ent siRNA molecular structures. We assume that once the
bound RISC complex is formed, it will cleave the mRNA
with the same rate irrespective of the presence of the over-
hangs on the siRNA. Findings in Ref [14] suggest that the
direction of Dicer processing confers some kind of func-
tional polarity, possibly at the level of RISC loading. How-
ever, the mRNA cleavage reaction rate has not been
explicitly studied for different types of siRNAs as yet.
Hence, our first contribution is a chemical kinetic theory
based analytical model for measuring the rate constant of
the siRNA-RISC complex formation reaction. The two dif-
ferent rate constants predicted by this model for the differ-
ent siRNA structures were then fed into a stochastic
simulation (using the widely used Gillespie stochastic
simulator [15]) to study the potency effects. This gave us a
relative quantification between the gene silencing period
and the concentration of the two types of siRNA mole-
cules required to keep the mRNA count at the same level.
We also incorporated the gene transcription/translation
reactions to study whether a burst in mRNA production
[16] has a role to play in the RNAi system.
Reaction model
Consider the elementary reaction with three types of mol-
ecules siRNA, RISC and the siRNA-RISC complex:
We divide the reaction event into two independent micro-
events as follows; 1) Random collisions between the reac-
tants; this allows us to compute the probability of colli-
sion (pc) between the reactant molecules. 2) A reaction
will occur only when the kinetic energy of the colliding
reactant exceeds the activation energy requirement for the
reaction. Using these two events, allows us to compute the
probability of reaction (pr).
The total probability for reaction after a collision is hence
the joint probability of these two events. To model this
reaction analytically in the time domain, we first assume
that the siRNA molecules enter the cell one at a time. Note
that siRNAs are typically delivered via transfection thereby
introducing a bolus of molecules into the cell. Thus, we
need to consider the effective number of siRNAs in the cell
while computing the binding rate. We will show how the
computations change while we consider a certain concen-
tration of siRNA molecules for deriving the overall bind-
ing rate subsequently in this section. We also assume that
the cell contains a fixed number, n2, of RISC molecules.
Note that while modeling the reaction, it is not necessary
to consider the fact that the siRNAs or RISC complexes can
also take part in other reactions with other reactants or can
degrade independently. The time domain model is based
solely on the current instance of these two reactants in the
cell as the time taken to complete this reaction will gener-
ally be less in comparison to the time taken to degrade a
siRNA or a RISC molecule. The idea here is to discretize
this reaction from other competing reactions that can
change the concentrations of the siRNA/RISC molecules.
Though this approximation might lead to less accurate
predictions of the binding rate for this reaction, we can
still consider the effects of such competing reactions by
the system simulation of the RNAi pathway (as shown
later).
We follow the principles of collision theory for hard
spheres [17] to model the chemical kinetics of the reac-
tion. As shown in Figure 2, we model each reactant mole-
cule as a rigid sphere with radii r1 and r2 for the siRNA and
RISC molecules respectively. We define our coordinate
system such that the RISC molecule is stationary with
respect to the siRNA molecule for the reaction, so that the
siRNA moves towards the RISC molecule with a relative
velocity U12. The siRNA molecule moves through the cell
cytoplasm to sweep out a collision cross section A = π r122
(as illustrated in Figure 3), where r12 is the collision radius
given by: r12 = r1 + r2. If the center of a RISC molecule
comes within a distance of r12 of the center of a siRNA
molecule, they will collide which might result in a success-
ful reaction.
To discretize the system, we consider the dynamics of this
process within a small time Δt. We assume that the tem-
poral reaction process is an independent sequence of
siRNA RISC siRNA RISC+ → −
Schematic diagram of siRNA and RISC moleculesFigure 2
Schematic diagram of siRNA and RISC molecules.
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events separated by Δt. In time Δt, the siRNA molecule
sweeps out a volume ΔV given by: ΔV = π r122 U12 Δt. Note
that, in Figure 3 the siRNA molecule actually sweeps out a
cylindrical volume that allows us to estimate ΔV as the
length of the cylinder in time Δt, thus is given by U12 Δt.
Now, the probability of a siRNA molecule being present
in the collision volume ΔV is psiRNA = 1. This is because we
have already assumed that one siRNA molecule entered
the cell creating a collision volume of ΔV.
Probability of at least one molecule of RISC being present
in an arbitrary uniformly distributed ΔV in V is pRISC =ΔV.n2/V, where V denotes the cell volume. Ideally V
should be the volume of the cytoplasm, which can be
approximated by the entire cell volume. The probability
that a siRNA molecule collides with a RISC molecule in Δt
is given by:
Thus we have a stochastic sequence of events character-
ized by the probability of collision, and it is important to
determine whether the collision will create the reaction.
To complete the reaction, the molecules have to bind to
each other. Different types of bonds (ionic, covalent,
hydrogen etc.) require different activation energies for
binding. We next assume that the colliding molecules
must cross an energy threshold, defined by the free energy
EAct, to provide the energy to react. Also, we assume that
only the kinetic energy directed along the line of centers
of the two reacting molecules contribute to the reaction as
the effects of other forces (e.g. coulomb force) can been
captured by the velocity distribution of the siRNA mole-
cules in the cell.
These two assumptions define the probability of another
independent event: successful reaction after collision
denoted by pr. The kinetic energy of approach of a siRNA
towards the RISC molecule with relative velocity U12 is E
= m12.U122/2, where m12 = m1.m2/(m1+ m2) = the reduced
mass, m1 = mass (in gm) of a siRNA molecule and m2 =
mass (in gm) of a RISC molecule. We also assume that as
E increases above EAct, the number of collisions that result
in reaction also increases linearly. Thus the probability for
a reaction to occur, pr, is given by:
and hence, the joint probability, p, for collision and reac-
tion is given by:
Until now we were working with a fixed relative velocity
U12 for the siRNA molecules. The velocity distribution of
the macromolecules inside a cell capturing the effects of
the different forces as obtained from Molecular Dynamic
Simulation is generally found to be comparable to the
Maxwell-Boltzmann distribution [18,19]. Hence, to
approximate the relative velocity of the siRNA molecules,
we use the Maxwell-Boltzmann distribution of molecular
velocities for a species of mass m given by:
where kb = Boltzmann's constant = 1.381 × 10-23 kg-m2/s2/
K/molecule and T is the absolute temperature at which the
reaction occurs. Replacing m with the reduced mass m12
of the molecules, we get,
The term on the left hand side of the above equation
denotes the fraction of siRNA molecules with relative
velocities between U and (U+dU). Summing up the colli-
sions for the siRNA molecules for all velocities we get the
probability of reaction, p, as a function of temperature
only as follows:
p p .p
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Now, recalling E = m12.U122/2, i.e., dE = m12U12dU and
substituting into the expression for f(U, T)dU, we get:
Thus we get:
To consider a certain concentration of siRNA molecules,
we assume that n1 number of siRNA molecules are present
in the cell. This will increase the probability of a successful
reaction by a factor of n1, and hence we have:
We discretize the temporal reaction process as a Bernoulli
trial process. Next we compute the average time taken to
complete the reaction with this probability. Let us assume
that the molecule composition does not change during
the reaction time. This is valid due to the very short time
for reaction compared to the time taken for a potential
change in the reaction environment for the associated
molecules. The molecules try to react through repeated
collisions. If the first collision fails to produce a reaction,
they collide again after Δt time units and so on. We can
interpret p as the probability of a successful reaction in
time Δt. Thus the average time of reaction, Tavg, can be
approximated by summing up the times taken for a suc-
cessful reaction by the first collision, or that by the second
collision and so on. Thus we get:
Similarly, the corresponding second moment, T2ndmoment,
can be formalized by
This gives us the first and second moments of the reaction
time, which is considered to be a random variable. The
binding rate for this reaction can be easily estimated as 1/
Tavg although the reaction is essentially stochastic. Note
that, the expression for the binding rate from our model is
exactly the same as that derived by chemical kinetic mod-
eling of reaction rates. However, our model allows us to
study the inherent stochasticity of the reaction consid-
ered.
Estimating the reaction rate constant for the siRNA 
molecules
The above model was used to study the binding rate of
siRNA molecules. Note that the model requires an esti-
mate of the activation energy for the siRNA-RISC complex
formation reaction. However, it is very difficult to experi-
mentally measure the activation energy required for a
reaction. The activation energy is generally derived from
the heat of reaction (-ΔH0) by using the Polyani equation
[17]. But it is equally difficult to measure the heat of reac-
tion specifically for those occurring inside the cell.
We observed that the siRNA-RISC reaction occurs when
the siRNA duplex breaks down into two single-stranded
molecules one of which enters the reaction (the antisense
strand), while the other (the sense strand) disintegrates.
The antisense strand enters into a docking reaction with
the RISC complex. Thus, we can rewrite the siRNA-RISC
complex formation reaction in the following form:
Note that we treat the double stranded siRNA as a com-
plex between the sense (siRNAsense) and antisense (siR-
NAantisense) strands. Referring to the reaction model
discussed above, the two colliding macromolecules will
be the siRNAsense siRNAantisense and RISC complexes. This
also motivates the use of the Polyani equation for measur-
ing the activation energy, which particularly works well
for the following family of reactions:
Spectometric measurements on the thermodynamics of
double-helix formation reported in Refs. [20] and [21]
reveal the contribution of the 3' end in increasing the sta-
bility of the helix. Ref. [22] also relates the sequence
dependence to the Gibb's free energy change to study the
energetics of dangling ends and terminal base pairs in
ribonucleic acid.
Hence, to measure the heat of reaction, we can use the
heat of reaction required to dissociate the siRNA duplex.
Note that, the second part of the reaction being essentially
a docking reaction does not require any activation energy
p T p f U T dU
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[23]. However, instead of using the actual heat of reaction
(measured in terms of the change in enthalpy for the reac-
tion), we plan to use the Gibb's free energy change
(ΔG370) that measures the "useful" or process-initiating
work. The idea is that only the Gibb's free energy (which
is a subset of the enthalpy or heat of reaction) is required
for the overall reaction to occur, as the remaining heat will
be generated by the docking part of the reaction. The
docking reaction as mentioned before does not require
any activation energy as it does not require changes in the
chemical structure (i.e., no reaction is required), and in
fact most binding events involve non-bonding interac-
tions. As a consequence, such complexes may be formed
by crossing small energy barriers that are within the range
of thermal fluctuations (kT range at physiological temper-
ature), and would not necessarily require a large kinetic
energy during the collision. However, the electrostatic and
solvation effects are the driving force for the formation of
macromolecular complexes, and hence the docking part
of the reaction. Hence, the activation energy, EAct will have
the following components:
where, Edissociation is the energy required for the dissocia-
tion of the double-stranded siRNAs while Eelectrostatic and
Esolvationcorrespond to the electrostatic and solvation
energy requirements for the docking reaction.
The Polyani equation for exothermic reactions is used for
estimating Edissociation from the Gibb's free energy measure-
ments as follows:
A recent study on siRNA duplex stability [24] gives the
thermodynamic energy requirements for 6-nt long siRNA
duplex stability. We used the Gibb's free energy change
measured by them for different types of residues present
in the 2-nt overhangs to generate the binding rates pre-
dicted by our model. An 8-fold difference in the reaction
rate was observed suggesting a purine residue followed by
a purine/pyrimidine residue in the overhang results in an
8-fold slowdown of the reaction rate (the first 20 data
points in Figure 4) compared to a pyrimidine residue fol-
lowed by a purine/pyrimidine residue which supports the
findings in Ref. [24]. The other parameters from the
model (e.g., mass and radii of siRNAs and RISC enzymes)
were arbitrarily assumed as we are interested in the relative
difference in the binding rates for the different siRNAs
instead of the actual values. Also, it should be noted that
the mass and radii of the different siRNAs in Ref. [24] will
be comparable and will not affect the binding rate appre-
ciably.
Ref. [24] also allows us to find out the distribution of the
reaction time for the siRNA molecules reported from the
Gibb's free energy estimates reported in Table 1 in Ref.
[24]. In Figure 5, we plot the standard deviation-to-mean
ratio of the reaction time from our model using the above-
mentioned activation energy estimate. We observe that
the standard deviation and mean times for reaction are
the same, and hence the reaction time follows an expo-
nential distribution. Thus, we can use the standard
Gillespie stochastic simulator for studying the RNAi sys-
tem where each reaction is considered stochastic, with the
time for reaction completion following an exponential
distribution.
With the above findings, we estimated the Gibb's free
energy change for dissociating the 21-nt siRNA duplexes
of the following two types: 1) 21-nt siRNAs with 2-nt
overhangs and 2) 21-nt blunt-ended siRNAs. The corre-
sponding ΔG370 estimates are -21.2 kcal/mol and -20.4
kcal/mol respectively. The experimental setup is explained
in the Appendix. This results in a 2-fold difference in the
rate constant using these two types of molecules with the
blunt-ended ones having a lower rate constant than their
2-nt overhang counterparts (i.e. Tavgblunt-end/Tavg2-nt = 2,
where Tavgblunt-endand Tavg2-nt are the average reaction times
for blunt-ended and 2-nt siRNAs respectively). Again we
have assumed that the mass and radii of these two types
of siRNAs are comparable and only the activation energy
parameter from our reaction model makes the rate con-
stant different. Also, note that the cell volume parameter
cancels out as we only need to compute the ratio (Tavgblunt-
end/Tavg2-nt) and not the actual rate constants. Similarly, we
have assumed that Eelectrostatic and Esolvation will be the com-
parable for the two types of siRNAs and will cancel out as
we compute Tavgblunt-end/Tavg2-nt. Note that Eelectrostatic can
E  = EAct dissociation + +E Eelectrostatic solvation (12)
E  = 48.1 + 0.25(G )dissociation 37
0 (13)
Binding rate constant plotF gure 4
Binding rate constant plot.
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be computed using the siRNA 3-d structures using stand-
ard software like Delphi [25] but will be very similar for
the siRNAs that we have considered (which only differ by
2-nt at the 3' end). We next use this predicted difference in
rate constants to compare the potency effects of these two
types of molecules in an entire RNAi system simulation.
Note that, because of the unavailability of some of the
parameters required in the model (that we have assumed
to be comparable for the two types of siRNAs), we have
used the rate constant reported in Ref [26] for 2-nt siRNAs
directly in the simulation model. To get the rate constant
for blunt-ended siRNAs, we halved the rate constant as
predicted by our reaction model.
siRNA duplex stability measurements
Blunt-end and 2-nt 3' overhang siRNA's were reconsti-
tuted in buffer at 20 μM. Stock solutions were then diluted
in buffer to 10 μM for data collection and determination
of the thermodynamic parameters for siRNA unfolding.
120 μL of solution was added to a micro-volume UV
cuvette with a pathlength of 1.0 cm. The cuvette was
placed in an AVIV UV/Vis spectrophotometer with a Pel-
tier temperature controller. A reference cuvette filled with
buffer solution was placed in the reference beam. The
temperature was lowered to 10°C and the absorbance at
280 nm was auto zeroed. Temperature was then increased
at 1°C/min and the change in absorbance recorded until
the temperature reached 95°C. Absorbance data were
exported to Meltwin 3.5 software [27] for data analysis.
Data were fit to the self-complimentary model available
in Meltwin 3.5.
Results
Stochastic simulation of the RNAi system
We primarily employed Dizzy [28] and the SimBiology
toolkit from Matlab for the stochastic simulation of the
RNAi system. Let us consider a simple RNAi system from
Table 1. mRNA is transcribed according to reaction 4 and
degraded according to reaction 6. dsRNA is synthesized
from mRNA by RDR and is cleaved into 10 siRNAs accord-
ing to reactions 3 and 2 respectively. siRNA can associate
with mRNA according to reaction 1 to cleave the mRNA
and produce garbage RNA (gRNA). For simplicity, we do
not implement the formation of RISC explicitly in our
model; instead, the siRNA-mRNA complex is directly
degraded into aberrant gRNA. Thus, we assume that the
RISC enzymes are not a rate limiting component of the
RNAi system. Reactions 5 and 7 describe the degradation
of siRNAs and aberrant garbage pieces, respectively. This
simple RNAi system is motivated from [26] from where
we get an estimate of the basic rate constants. We did not
consider any nonspecific effects following the observation
in Ref. [29] that siRNA-mediated inhibition of gene
expression is generally independent of nonspecific inter-
ference pathways triggered by the dsRNAs. Our goal in
this study is to present a systems biology framework for
studying the potency effects of the two types of siRNA
based on the difference in their rate constants. Thus, the
rate constant of reaction 1 is 0.008 for siRNAs with 2-nt
overhangs while it will be approximately 0.004 for the
blunt-ended molecules.
Table 2 presents the initial number of molecules consid-
ered in the cell for the simulation. These values are just for
illustrative purposes but serve well to compare the two
types of siRNAs. In Figures 6 and 7 we report the change
in concentration of the dsRNA and mRNA molecules with
time (in hours) for the 2-nt overhangs and blunt-ended
molecules respectively. Note that the dsRNA molecules
get used up quite quickly (in less than 3 hours) in both
cases depending on the siRNA production rate from dsR-
NAs and dsRNA degradation. However, for blunt-ended
siRNAs, the mRNA levels go down to about 250 molecules
(in about 3 hours) compared to about 150 molecules
when the 2-nt overhang siRNAs are used. This is obvious
as the siRNA-RISC complex formation reaction rate for
Table 1: Simple RNAi system equations
Reaction Rate Constant
1 mRNA + siRNA -> gRNA 0.008 hr-1
2 dsRNA -> 10*siRNA 2.0 hr-1
3 mRNA -> dsRNA 0.002 hr-1
4 ϕ-> mRNA 160.0 hr-1
5 siRNA -> ϕ 2.0 hr-1
6 mRNA -> ϕ 0.14 hr-1
7 gRNA -> ϕ 2.8 hr-1
The mean and standard deviation of reaction time are fairly equal and hence the reaction time is assumed to follow an xpon ntial distributionFigure 5
The mean and standard deviation of reaction time 
are fairly equal and hence the reaction time is 
assumed to follow an exponential distribution.
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blunt ended molecules is about half of that for 2-nt over-
hang siRNAs. Another point worth noting is that the
mRNA levels return to control levels or untreated levels
after a longer period when blunt-ended molecules are
used. This can be attributed to the fact that the rate con-
stant for the siRNA-RISC complex formation reaction
being low for blunt-ended molecules, the blunt-ended
siRNAs persist in the system for a longer time than the 2-
nt 3' overhang counterparts. Figure 8 illustrates this phe-
nomenon, where the mRNA levels using blunt-ended siR-
NAs seem to lag behind that observed for the 2-nt
overhang species. The plot was generated with the initial
concentration of dsRNA molecules set to 100 for illustra-
tive purposes.
Next we consider the transcription/translation machinery
to study the potential effects of stochastic mRNA produc-
tion on the RNAi system [30]. The additional reactions
(7–18) were added to consider the transcription/transla-
tion processes (presented in Table 3) and the initial con-
ditions are reported in Table 4. A single gene is transcribed
into mRNA by RNA polymerase (RNAP). The process is
initiated with the binding of RNAP to the promoter, usu-
ally near the beginning of the transcribed sequence.
Expression of most genes are regulated at the level of tran-
scription and more specifically during the initiation of
transcription, that is, before the first phosphodiester bond
is formed.
Figures 9 and 10 report the mRNA and dsRNA concentra-
tion changes with time for this combined RNAi system.
We observe similar effects (both quantitative and qualita-
tive) as in the simple system without considering the tran-
scription/translation reactions. Note that the simple
system considered a certain mRNA production rate and
does not capture the uneven mRNA production observed
recently [16]. Because of stochastic gene expression in
eukaryotic cells, mRNA and hence protein production is
erratic and occurs in bursts. The average intervals between
bursts is longer in eukaryotes compared to prokaryotes
[16]. Thus, the stochasticity in gene expression does not
have any observable effects in the RNAi system. One plau-
sible reason behind this is the fact that the stochasticity is
observed at a much lower time scale (generally in sec-
onds) while we in this simulation, are interested in study-
ing the mRNA concentrations over a longer time scale
(hours). Initial findings show about 1.5 times more blunt-
ended molecules will be required to keep the mRNA at a
certain low level. Figure 11 plots the mRNA levels for dif-
ferent types of siRNAs in order to quantify the gene silenc-
ing period. With 10,000 dsRNA molecules for the two
types of siRNAs, the silenced period is larger for 2-nt over-
hang siRNAs. Using 15,000 dsRNAs of blunt-ended type
we can achieve the same amount of silencing as the 2-nt
overhang siRNAs.
Next consider the effects of the RDR mechanism of replen-
ishing the dsRNAs in the cell. Using the simple RNAi sys-
tem (of Table 1), as the transcription/translation
machinery failed to show any significant changes in the
system behavior. Table 5 lists the additional reactions to
Concentration change blunt-ended siRNAsFigure 7
Concentration change blunt-ended siRNAs.
Table 2: Initial conditions
Reactant Number of molecules
mRNA 1000
siRNA 0
dsRNA 200
gRNA 0
Concentration change using 2-nt 3'siRNAsFigure 6
Concentration change using 2-nt 3'siRNAs.
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incorporate the RDR mechanism. Reaction 8 describes the
unprimed amplification – the synthesis of dsRNA from
aberrant garbage RNA by RDR; and reaction 9 describes
primed amplification – the synthesis of dsRNA primed by
the presence of a siRNA on mRNA. We consider the path-
way with the amplification terms at both low and high
amplification rates (Figures 12 and 13 respectively). Thus
sustained gene silencing can only occur through the RNAi
pathway if there is a way of replenishing the dsRNAs in the
cell. This can occur through the RDR mechanism (with
high amplification as illustrated in Figure 13), or through
artificial dsRNA injection into the cell (Figure 14) at cer-
tain time periods. There is no conclusive evidence of the
presence of the RDR mechanism in mammalian cells, and
hence the artifical dsRNA injection will play a very impor-
tant role in any RNAi based therapeutic tool.
There is a slight difference in the mRNA levels with the 2-
nt overhang siRNAs fairing a little better than their blunt-
ended counterparts. However, we can get a relative quan-
tification of the number of dsRNA molecules required to
be inserted into the cell for two types of siRNAs consid-
ered to keep the mRNAs down at the same level. This will
require more real-life initial concentration values for the
other components of the RNAi system and also a model
to predict the average number of dsRNA molecules that
actually enter a single cell depending on the dosage
amount and intervals. Our model provides a simulation
framework that will help us study the gene silencing dura-
tion using siRNAs in the future.
Discussion
Handling delayed reactions
We have computed the time taken to complete the reac-
tion. The underlying assumption is that reactant collisions
occur with some probability and once a collision of suffi-
cient energy occurs, a reaction takes place instantane-
ously. Hence, we assume that there is no time delay to
form an activated complex. If there is some time delay
associated with initiation and completion of the reaction,
the probability evolution becomes more complicated
[31]. Our reaction model cannot directly handle such
delayed reactions, which would require comprehensive
modeling of the delayed states. However, the reaction
model in this paper was primarily developed for the
Table 3: RNAi system with transcription/translation machinery
Reaction Number Reaction Rate Constant Remarks
1 mRNA + siRNA -> gRNA 0.008 hr-1
2 dsRNA -> 10*siRNA 2.0 hr-1
3 mRNA -> dsRNA 0.002 hr-1
4 siRNA -> ϕ 2.0 hr-1
5 mRNA -> ϕ 18 hr-1
6 gRNA -> ϕ 2.8 hr-1
7 O + R -> O_R 12.0 hr-1 Regulatory molecule R binds to the operator region O to form the 
bound complex O_R
8 O_R -> O + R 0.24 hr-1 O_R dissociates into free R and O
9 P + RNAP -> P_RNAPC 1.2 hr-1 RNAP binds to promoter region P forming closed complex P_RNAPC
10 P_RNAPC -> P + RNAP 0.06 hr-1 P_RNAPC dissociates into free RNAP and P
11 P_RNAPC -> P_RNAPO 48 hr-1 Isomerization of closed to open complex (P_RNAPO)
12 P_RNAPO -> TrRNAP + mRNA + P 54 hr-1 RNAP clears promoter region and mRNA chain synthesis starts. 
TrRNAP denotes transcribing RNA polymerase.
13 TrRNAP -> RNAP 4.8 hr-1 RNAP completes transcription and is released from DNA.
14 mRNA + Ribosome -> RibRBS 0.6 hr-1 Ribosome binds to mRNA forming bound complex RibRBS
15 RibRBS -> mRNA+ Ribosome 0.06 hr-1 Ribosome dissociation from RibRBS
16 RibRBS -> EIRib + mRNA 18 hr-1 Ribosome EIRib initiates translation of mRNA chain
17 EIRib -> protein 48 hr-1 Protein synthesis by transcribing ribosome
18 protein -> ϕ 0.18 hr-1 Protein product degradation
mRNA levels saturate after longer time while blunt-ended si s ar  usedFigure 8
mRNA levels saturate after longer time while blunt-
ended siRNAs are used.
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siRNA-RISC complex formation reaction, which does not
require the handling of delayed reactions. However, this
involves an implicit approximation that the reactant mol-
ecules are not available for other reactions once it has
entered the present reaction event. But because both the
original reaction event time and the delay can be random
variables incorporating the probability of successfully
completing the delayed reaction event, this approxima-
tion should be small. Further analysis is required to study
the effect of this approximation.
Maxwell-Boltzmann distribution of molecular velocities
The Maxwell-Boltzmann distribution gives a good esti-
mate of molecular velocities where we have spatial homo-
geneity and is widely used in practice. Molecular dynamic
(MD) simulation measurements during protein reactions
show that the velocity distribution of proteins in the cyto-
plasm closely matched the Maxwell-Boltzmann distribu-
tion [18,19]. However, its application in our model may
not give the predicted results for cases that violate the
assumption of uniform distribution in a volume. Ideally
the velocity distribution should incorporate the properties
of the reaction space (nucleus/membrane/cytoplasm for
reactions occurring in the membrane, nucleus or cyto-
plasm) and the effect on velocity distribution due to its
space shape and irregularities. We plan to explore the pos-
sibility to improve this velocity distribution by consider-
ing the other biological factors that can influence the
velocity of the reacting molecules.
Activation energy threshold
The activation energy has been measured for many reac-
tions and we need an estimate of this parameter to be able
to predict the nature of the reaction time. We used the
Polyani equation to compute Edissociation for the reaction by
measuring the Gibb's free energy change to dissociate a
siRNA duplex. As discussed before, this approximation
can give us a relative difference in the reaction rates for the
two types of siRNAs used in our study, but will fail to give
us a direct quantification of the actual reaction rates
(which will also require estimates of Eelectrostatic, Esolvation,
mass, radii etc. for the siRNAs). We are exploring ways to
measure the actual heat of reaction for the entire siRNA-
RISC complex formation reaction and the other parame-
ters to make the model predictions more accurate.
Reverse reactions
We did not consider the reverse reaction conditions in our
model because we assumed the siRNA-RISC complex for-
Combined RNAi system plot using blunt-ended siRNAsFigure 10
Combined RNAi system plot using blunt-ended siR-
NAs.
Table 4: Initial Conditions for the combined RNAi system
Reactant Number of molecules
mRNA 1000
siRNA 0
dsRNA 200
gRNA 0
R 20
O 1
O_R 0
P 200
RNAP 400
P_RNAPC 0
P_RNAPO 0
TrRNAP 0
Ribosome 350
RibRBS 0
EIRib 0
protein 0
Combined RNAi system plot using 2-nt 3'siRNAsFigure 9
Combined RNAi system plot using 2-nt 3'siRNAs.
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mation reaction as non-reversible. However, the Gillespie
stochastic simulation framework allows us to incorporate
reversible reactions if we know the forward and backward
reaction rates [15]. We plan to make the simulation
framework presented in this paper more comprehensive
once we have experimental measure of these reaction
rates.
Reaction neighborhoods
In addition, there is increasing evidence of sub-compart-
mental (i.e., intra-compartmental localization) in cells, so
local neighborhoods of reactions will have higher appar-
ent concentrations than simply the number of molecules
divided by the size of the compartment. However, this
would require more in depth modeling of the different
molecular concentrations inside the cell that reduces the
scalability of the stochastic simulation framework.
Indeed, the Gillespie simulator fails to address this issue
as it requires different rate constants for specific neighbor-
hoods of the reaction type. Nevertheless, our model can
be easily extended to incorporate such reaction neighbor-
hoods by limiting the movement of the reactant mole-
cules inside a reaction space while computing the
probability. However, the applicability of the Maxwell-
Boltzmann velocity distribution in the neighborhood
requires further research.
Role of GW/P-bodies in RNA silencing
A related concern with this simulation model is the recent
finding that RISC and other enzymes involved in RNA
degradation tend to localize to discrete cytoplasmic foci
known as P-bodies [32,33]. Moreover, siRNAs were also
observed to localize to specific cytoplasmic compartments
in the periphery of the nucleus in granular-like structures
[34]. This compartmentalization will have an effect on the
reaction model that we have developed based on the
entire cell volume. However, it should be noted that the
reaction model is only used to find the relative difference
in the reaction rates between the two types of siRNAs and
not to predict the overall reaction rate. We have used the
reaction rates reported in Ref [26] in our simulation
model and changed it accordingly for blunt ended siRNAs
using the reaction model. Also, finding the relative differ-
ence in the reaction rates would mean the cancellation of
the parameter V, and hence is independent of the effects
of this compartmentalization. It can be argued that the
simulation model however requires additional reactions
to address the effect of GW/P-bodies (e.g., by adding addi-
tional delay for siRNAs to reach the cytoplasmic foci and
additional reactions for forming the complex with GW/P-
bodies). This will require additional research to estimate
the kinetic parameters for these reactions. In this paper,
however, we can neglect the effect of GW/P-body forma-
tions because the reaction rate mentioned in Ref [26] is for
the overall siRNA-mRNA complex formation reaction and
should already incorporate the effects of this compart-
mentalization.
27-mer RNA duplexes show higher potency than 21-mer 
siRNAs
Many researchers today employ synthetic 21 mer RNA
duplexes as their RNAi reagents, which mimic the natural
siRNAs that result from Dicer processing of dsRNAs. An
alternative approach is to use synthetic RNA duplexes that
are greater than 21 mer length which are substrates for
Dicer. These duplexes are typically 27-nt long and are
processed by Dicer into 21 mer siRNAs. It has been
reported that synthetic Dicer-substrate RNAs can have sig-
nificantly increased potency (~100-fold) when compared
with 21 mer duplexes [35,36]. The 100-fold increase in
potency of the 27 mer is due to a combination of Dicer
cleavage resulting in "a better 21 mer" (10-fold increase)
plus some other effect that required use of the intact 27
mer (another 10-fold increase).
Table 5: Additional reactions from Table 1 to consider the RDR mechanism
Reaction Number Additional Reactions from Table 2 High Amplification Low Amplification
8 gRNA -> dsRNA 0.4 hr-1 0.02 hr-1
9 mRNA + siRNA -> dsRNA 0.002 hr-1 0.0002 hr-1
Quantification of gene silencing period with different types of siRNAsFigure 11
Quantification of gene silencing period with different 
types of siRNAs.
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More recent works targeted additional sites in other genes,
to find examples where the longer RNAs had greater
potency, the same potency, and lower potency than 21
mers at the same site. This wide variation in performance
was primarily attributed to the differences in dicing pat-
terns: sometimes Dicer processing resulted in a "good" 21
mer while other times it resulted in a "bad" 21 mer (Ref
[14]). Small shifts in sequence can have a large effect on
siRNA potency. Combination of asymmetric 2-base 3'-
overhang with 3'-DNA residues on the blunt end result in
a duplex form which directs dicing to predictably yield a
single primary cleavage product. Using this strategy,
strand targeting experiments in Ref [14] show that Dicer
processing confers functional polarity within the RNAi
pathway.
In this work, we have not studied the effects on potency
while using synthetic 27 mers instead of the dsRNAs. This
will require the ratios of the "good" and "bad" 21 mers
that are diced from the 27 mers entering the cell as well as
a similar thermodynamic stability study of these 21 mers
to study their effects on the rate constant estimates.
Conclusion
The RNAi system simulation framework developed here
presents some qualitative and quantitative results on the
RNAi pathway. The simulation also explores the potency
effects of the two types of siRNAs considered. We prima-
rily focused on identifying the most important compo-
nents of the system that play a role in identifying the
potency effects. This framework can be extended to pre-
dict very important features of the RNAi pathway includ-
ing the duration of gene silencing for the different siRNA
molecules. This will require models to study the effective
rate of dsRNA entry into the cell depending on the
amount of dosage and dosage intervals. We plan to study
2-nt 3'and blunt-ended siRNAs with artificial dsRNA injec-tionFigure 14
2-nt 3'and blunt-ended siRNAs with artificial dsRNA 
injection. Fiureg 14 show the effects of artificial dsRNA 
injection (for the simple RNAi system of Table 1) for the two 
types of siRNAs with 200 dsRNA molecules inserted every 
hour into the cell.
2-nt 3' and blunt-ended siRNAs with RDR show the mRNA/dsRNA concentration changes with time at low amplification through RDR fo  he two type of siRNAs c nsideredFigure 12
2-nt 3' and blunt-ended siRNAs with RDR show the 
mRNA/dsRNA concentration changes with time at 
low amplification through RDR for the two types of 
siRNAs considered. We do find an expected increase in 
the potency effects for both types of siRNAs (compared to 
Figures 6 and 7).
2-nt 3' and blunt-ended siRNAs with RDRFigure 13
2-nt 3' and blunt-ended siRNAs with RDR. Figure 13 
shows the effects of high amplification through RDR and we 
can observe sustained gene silencing. The actual mRNA levels 
will however depend on the amplification rates and initial 
number of dsRNA molecules inserted into the cell.
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these important aspects of the RNAi system, once we build
more fidelity on this simulation framework.
The proposed model computes the reaction time for the
siRNA-RISC complex formation reaction as a stochastic
variable that appropriately reflects the cell environment.
The concept of the model is to transform the reaction
process from a continuous deterministic process to a dis-
crete random one. The model allows the transformation
of biological reactions to the stochastic domain and
makes it suitable for a stochastic simulation of the RNAi
system. The average reaction time estimated from this
method is exactly the same as the reaction rate estimates
of kinetic modeling. In addition, we are able to estimate
the first two moments of the reaction time to capture the
stochastic nature of the reaction. The reaction model was
used to study the difference in binding rate for the 2-nt 3'
overhang siRNAs and the blunt-ended siRNAs, and we
found that the reaction rate is predicted to double when
2-nt 3' overhang siRNAs are used. We next built an RNAi
stochastic system simulation using the Gillespie simulator
to study the overall potency effects of the two types of siR-
NAs. Initial findings suggest that about 1.5 times more
blunt-ended siRNAs are required to keep down the mRNA
at the same level as using 2-nt 3' overhang siRNAs. The
additional blunt-end siRNAs may be needed because the
siRNA-RISC complex formation reaction is not the only
part of the RNAi pathway that is affected by the presence
of the 2-nt overhangs in the siRNA molecules. The reac-
tion in which the bound RISC complex cleaves the mRNA
might be affected more due to the difference in the siRNA
structures. Further research is required to study this aspect
of the RNAi system.
The stochastic simulation framework presented here
allows us to predict some quantitative and qualitative
aspects of the RNAi system for the two different types of
siRNAs used in our study. More importantly, it allows us
to build a quantitative framework for studying the length
of the gene silencing period and number of siRNA mole-
cules (of both types) required for the same for a cost-
potency study. This will require a model to estimate the
average number of dsRNA molecules actually entering the
cell depending on the dosage interval and amount. The
initial predictions from our work are promising, as we
plan to build a computational tool for studying the thera-
peutic effects of the RNAi pathway.
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